
Collate is an AI platform designed to automate and streamline the creation of paperwork for companies in the diagnostic, medical device, and drug development sectors, covering the entire product lifecycle from concept to market. The company's mission is to accelerate life-saving innovations by producing accurate documentation, thereby enabling teams to focus more on core responsibilities and less on administrative tasks. Collate aims to deliver cutting-edge AI solutions securely and reliably, ultimately helping to bring life-saving innovations to patients sooner by reducing time to market for new drugs, diagnostics, and devices. They emphasize optimizing preclinical and clinical trials, enhancing quality management, and ensuring compliance with quality standards.

Collate is an AI platform designed to automate and streamline the creation of paperwork for companies in the diagnostic, medical device, and drug development sectors, covering the entire product lifecycle from concept to market. The company's mission is to accelerate life-saving innovations by producing accurate documentation, thereby enabling teams to focus more on core responsibilities and less on administrative tasks. Collate aims to deliver cutting-edge AI solutions securely and reliably, ultimately helping to bring life-saving innovations to patients sooner by reducing time to market for new drugs, diagnostics, and devices. They emphasize optimizing preclinical and clinical trials, enhancing quality management, and ensuring compliance with quality standards.
Product: AI platform that generates and manages regulatory and development documentation for diagnostics, medical device, and drug companies
Founders: Surbhi Sarna (CEO) and Nate Smith (CTO)
Security: Enterprise-grade security (AES-256 at rest, TLS, MFA/SSO) and zero-retention policies for third-party AI providers
Recent funding signal: Series A recorded (Crunchbase) with Venrock named as lead; Seed investors listed across records include Y Combinator, Redpoint, First Round Capital, Conviction Embed
Regulated documentation and compliance workflows for life-sciences product development
2025
DeepTech
Crunchbase funding record lists Seed investors including Y Combinator, Redpoint, First Round Capital, Conviction Embed
Series A recorded on Crunchbase with Venrock named as lead
“Y Combinator; Redpoint; First Round Capital; Conviction Embed; Venrock; Eudemian Ventures”
| Company |
|---|